ICC showed that MUC2 expression increased in the cells treated with 200 μM NAD+; however, it decreased upon co-treatment with 200 μM NAD+ and U0126 (Figure 8E). This evidence concerns the gene MUC2 and intrahepatic cholangiocarcinoma.